CML patients reportedly have increased BM vessel density and elevated serum levels of VEGF, HGF, FGF-b, and TNF-α compared to controls [23, 24]. The gene discussed is VEGFA; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.